Cargando…

Adverse effects of paternal chemotherapy exposure on the progeny brain: intergenerational chemobrain

Recent advances in cancer treatments have led to significant increases in cure rates. Most cancer patients are treated with various cytotoxic chemotherapy regimens. These treatment modalities are mutagenic and genotoxic and cause a wide array of late-occurring health problems, and even exert a delet...

Descripción completa

Detalles Bibliográficos
Autores principales: Kovalchuk, Anna, Ilnytskyy, Yaroslav, Woycicki, Rafal, Rodriguez-Juarez, Rocio, Metz, Gerlinde A.S., Kovalchuk, Olga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839372/
https://www.ncbi.nlm.nih.gov/pubmed/29515791
http://dx.doi.org/10.18632/oncotarget.24311
_version_ 1783304396763824128
author Kovalchuk, Anna
Ilnytskyy, Yaroslav
Woycicki, Rafal
Rodriguez-Juarez, Rocio
Metz, Gerlinde A.S.
Kovalchuk, Olga
author_facet Kovalchuk, Anna
Ilnytskyy, Yaroslav
Woycicki, Rafal
Rodriguez-Juarez, Rocio
Metz, Gerlinde A.S.
Kovalchuk, Olga
author_sort Kovalchuk, Anna
collection PubMed
description Recent advances in cancer treatments have led to significant increases in cure rates. Most cancer patients are treated with various cytotoxic chemotherapy regimens. These treatment modalities are mutagenic and genotoxic and cause a wide array of late-occurring health problems, and even exert a deleterious influence on future offspring. The adverse effects from exposed parents on offspring are referred to as transgenerational effects, and currently little is known about chemotherapy-induced transgenerational effects. Furthermore, transgenerational effects have not been studied in the brains of progeny of exposed parents. In this study, we analyzed the existence and molecular nature of transgenerational effects in the brains of progeny of animals exposed to three common chemotherapy agents: cyclophosphamide (CPP), procarbazine (PCB) and mitomycin C (MMC). For the first time, our results show that paternal exposure to chemotherapy drugs causes transgenerational changes in the brain of unexposed progeny. Although no DNA damage was observed in terms of γH2AX levels, some alterations were found in levels of PCNA, protein involved in DNA repair, replication and profileration. Furthermore, there were changes in proliferation and apoptosis proteins BCL2 and AKT1, the proteins associated with DNA methylation, DNMT1 and MeCP2. Some altered expression trends were noted in proteins involved in myelin biogenesis, MBP and MYT1L. Moreover, global transcriptome profiling revealed changes in over 200 genes in the whole brains of progeny of animals exposed to CPP, and the changes in the levels of FOXP2 and ELK1proteins were confirmed by western blot analysis. These findings suggest that paternal chemotherapy significantly affects offspring brain development and may affect brain functioning. This research provides a key roadmap for future investigations of the novel phenomenon of transgenerational effects of chemotherapy in the brain of progeny of exposed parents.
format Online
Article
Text
id pubmed-5839372
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-58393722018-03-07 Adverse effects of paternal chemotherapy exposure on the progeny brain: intergenerational chemobrain Kovalchuk, Anna Ilnytskyy, Yaroslav Woycicki, Rafal Rodriguez-Juarez, Rocio Metz, Gerlinde A.S. Kovalchuk, Olga Oncotarget Research Paper Recent advances in cancer treatments have led to significant increases in cure rates. Most cancer patients are treated with various cytotoxic chemotherapy regimens. These treatment modalities are mutagenic and genotoxic and cause a wide array of late-occurring health problems, and even exert a deleterious influence on future offspring. The adverse effects from exposed parents on offspring are referred to as transgenerational effects, and currently little is known about chemotherapy-induced transgenerational effects. Furthermore, transgenerational effects have not been studied in the brains of progeny of exposed parents. In this study, we analyzed the existence and molecular nature of transgenerational effects in the brains of progeny of animals exposed to three common chemotherapy agents: cyclophosphamide (CPP), procarbazine (PCB) and mitomycin C (MMC). For the first time, our results show that paternal exposure to chemotherapy drugs causes transgenerational changes in the brain of unexposed progeny. Although no DNA damage was observed in terms of γH2AX levels, some alterations were found in levels of PCNA, protein involved in DNA repair, replication and profileration. Furthermore, there were changes in proliferation and apoptosis proteins BCL2 and AKT1, the proteins associated with DNA methylation, DNMT1 and MeCP2. Some altered expression trends were noted in proteins involved in myelin biogenesis, MBP and MYT1L. Moreover, global transcriptome profiling revealed changes in over 200 genes in the whole brains of progeny of animals exposed to CPP, and the changes in the levels of FOXP2 and ELK1proteins were confirmed by western blot analysis. These findings suggest that paternal chemotherapy significantly affects offspring brain development and may affect brain functioning. This research provides a key roadmap for future investigations of the novel phenomenon of transgenerational effects of chemotherapy in the brain of progeny of exposed parents. Impact Journals LLC 2018-01-23 /pmc/articles/PMC5839372/ /pubmed/29515791 http://dx.doi.org/10.18632/oncotarget.24311 Text en Copyright: © 2018 Kovalchuk et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Kovalchuk, Anna
Ilnytskyy, Yaroslav
Woycicki, Rafal
Rodriguez-Juarez, Rocio
Metz, Gerlinde A.S.
Kovalchuk, Olga
Adverse effects of paternal chemotherapy exposure on the progeny brain: intergenerational chemobrain
title Adverse effects of paternal chemotherapy exposure on the progeny brain: intergenerational chemobrain
title_full Adverse effects of paternal chemotherapy exposure on the progeny brain: intergenerational chemobrain
title_fullStr Adverse effects of paternal chemotherapy exposure on the progeny brain: intergenerational chemobrain
title_full_unstemmed Adverse effects of paternal chemotherapy exposure on the progeny brain: intergenerational chemobrain
title_short Adverse effects of paternal chemotherapy exposure on the progeny brain: intergenerational chemobrain
title_sort adverse effects of paternal chemotherapy exposure on the progeny brain: intergenerational chemobrain
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839372/
https://www.ncbi.nlm.nih.gov/pubmed/29515791
http://dx.doi.org/10.18632/oncotarget.24311
work_keys_str_mv AT kovalchukanna adverseeffectsofpaternalchemotherapyexposureontheprogenybrainintergenerationalchemobrain
AT ilnytskyyyaroslav adverseeffectsofpaternalchemotherapyexposureontheprogenybrainintergenerationalchemobrain
AT woycickirafal adverseeffectsofpaternalchemotherapyexposureontheprogenybrainintergenerationalchemobrain
AT rodriguezjuarezrocio adverseeffectsofpaternalchemotherapyexposureontheprogenybrainintergenerationalchemobrain
AT metzgerlindeas adverseeffectsofpaternalchemotherapyexposureontheprogenybrainintergenerationalchemobrain
AT kovalchukolga adverseeffectsofpaternalchemotherapyexposureontheprogenybrainintergenerationalchemobrain